Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

OBJECTIVES: To evaluate clinical outcomes in patients with diabetes, treated by cardiac resynchronization therapy with a defibrillator (CRT-d), and glucagon-like peptide 1 receptor agonists (GLP-1 RA) in addition to conventional hypoglycemic therapy vs. CRTd patients under conventional hypoglycemic...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cardiovasc Diabetol
المؤلفون الرئيسيون: Sardu, Celestino, Paolisso, Pasquale, Sacra, Cosimo, Santamaria, Matteo, de Lucia, Claudio, Ruocco, Antonio, Mauro, Ciro, Paolisso, Giuseppe, Rizzo, Maria Rosaria, Barbieri, Michelangela, Marfella, Raffaele
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2018
الموضوعات:
Original Investigation
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196445/
https://ncbi.nlm.nih.gov/pubmed/30348145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0778-9
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة